The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor.
The very low-density lipoprotein (VLDL) receptor: characterization and functions as a peripheral lipoprotein receptor.
复制标题
DOI:
10.5551/jat.11.200
复制
发表时间:
2004
影响因子:
4.4
通讯作者:
Sadao Takahashi;J. Sakai;T. Fujino;H. Hattori;Y. Zenimaru;J. Suzuki;I. Miyamori;Tokuo T. Yamamoto
中科院分区:
文献类型:
--
作者:
Sadao Takahashi;J. Sakai;T. Fujino;H. Hattori;Y. Zenimaru;J. Suzuki;I. Miyamori;Tokuo T. Yamamoto
The very low-density lipoprotein (VLDL) receptor is a member of the low-density lipoprotein (LDL) receptor family. In vitro and in vivo studies have shown that VLDL receptor binds triglyceride (TG)-rich lipoproteins but not LDL, and functions as a peripheral remnant lipoprotein receptor. VLDL receptor is expressed abundantly in fatty acid-active tissues (heart, skeletal muscle and fat), the brain and macrophages. It is likely that VLDL receptor functions in concert with lipoprotein lipase (LPL), which hydrolyses TG in VLDL and chylomicron. In contrast to the LDL receptor, VLDL receptor binds apolipoprotein (apo) E2/2 VLDL particles as well as apoE3/3 VLDL, and the expression is not down-regulated by intracellular lipoproteins. Recently, various functions of the VLDL receptor have been reported in lipoprotein metabolism, metabolic syndrome/atherosclerosis, cardiac fatty acid metabolism, neuronal migration and angiogenesis/tumor growth. Gene therapy of VLDL receptor into the liver showed a benefit effect for lipoprotein metabolism in both LDL receptor knockout and apoE mutant mice. Beyond its function as a peripheral lipoprotein receptor, possibilities of its physiological function have been extended to include signal transduction, angiogenesis and tumor growth.